A daganatjelzők meghatározásának szerepe a petef észekrákok kezelésében
Tumor Markers: AFP, CA 125, CEA, hCG, PSA - clin chem review - YouTube
Cancer Association of South Africa (CANSA)
Biochemical Markers of Colorectal Cancer – Present and Future | CMAR
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
tumor markers | PPT
Tumormarkerek a leleten – Rákos elváltozásra utalhat! | Youmed
:max_bytes(150000):strip_icc()/cancer-antigen-15-3-blood-test-for-breast-cancer-430608-Final-3ff12d280e8f4828beab8217d557c685.jpg "Cancer Antigen 15-3 Test: Uses, Procedure, Results")
Cancer Antigen 15-3 Test: Uses, Procedure, Results
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
tumor markers | PPT
Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review
Table I from Serum Tumor Markers in Hemodialysis Patients | Semantic Scholar
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
Kitasato Y, et al. Metastatic Pulmonary Adenocarcinoma 13 Years After Curative Resection for Pancreatic Cancer: Report of a Case and Review of Japanese Literature. JOP. J Pancreas (Online) 2012 May 10; 13(3):296-300.
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Tumor Markers - Pathology Made Simple
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Tumormarkerek - Medicover
Oncology
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
